MediaHealth
Dutch Media Fined for Overly Positive Ozempic Coverage
Dutch media giants DPG Media and Mediahuis face fines for overly positive Ozempic coverage, sparking a press freedom debate.
—4 min read
Tag
2 articles
Dutch media giants DPG Media and Mediahuis face fines for overly positive Ozempic coverage, sparking a press freedom debate.
New research at ASCO 2026 suggests GLP-1 drugs like Ozempic and Wegovy may reduce cancer risk and slow progression beyond weight loss.